Results 81 to 90 of about 8,780,675 (339)

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

No public health without planetary health

The Lancet Public Health, 2022
The Lancet Public Health
doaj   +1 more source

Virus and rickettsial diseases, with especial consideration of their public health significance [PDF]

, 1940
Javiera V. Arancibia C.
openalex   +1 more source

Public health and the public agenda [PDF]

This paper was presented as the distinguished address at the conference "Unequal incomes, unequal outcomes? Economic inequality and measures of well-being." The conference was held at the Federal Reserve Bank of New York on May 7, 1999.
Kevin Thurm
core  

Informed Alaskans Initiative: Public Health Data in Alaska [PDF]

, 2016
This article describes the national and state public health data made available online through the Alaska Division of Public Health's Informed Alaskans Initiative.[Introduction] / AK-IBIS / Health Indicators / Indicator Reports / Interactive Health ...
Armstrong, Barbara
core  

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Mitigating climate change must be a priority for public health

The Lancet Public Health, 2021
The Lancet Public Health
doaj   +1 more source

Correction: Variation in the incidence of type 1 diabetes mellitus in children and adolescents by world region and country income group: A scoping review.

PLOS Global Public Health
[This corrects the article DOI: 10.1371/journal.pgph.0001099.].
PLOS Global Public Health Staff
doaj   +1 more source

PUBLIC HEALTH. [PDF]

JAMA: The Journal of the American Medical Association, 1895
n ...
openaire   +1 more source

Tumor‐agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell‐free DNA fragmentomics

Molecular Oncology, EarlyView.
We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin, Kjersti Tjensvoll, Karin Hestnes Edland, Satu Oltedal, Herish Garresori, Bjørnar Gilje, Saga Ekedal, Trygve Eftestøl, Jan Terje Kvaløy, Filip Janku, Oddmund Nordgård   +10 more
wiley   +1 more source